Table 2. Oncologic outcomes among the BMI quartiles in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.
BMI quartiles† | Recurrence (%) | OR (95%, CI)* | P | CSM (%) | OR (95%, CI)* | P | OM (%) | OR (95%, CI)* | P |
---|---|---|---|---|---|---|---|---|---|
1 | 35 (31.8) | 1 | 34 (30.9) | 1 | 29 (26.4) | 1 | |||
2 | 22 (20.0) | 0.479 (0.243-0.942) | 0.033 | 15 (13.6) | 0.327 (0.159-0.674) | 0.002 | 11 (10.0) | 0.282 (0.126-0.630) | 0.002 |
3 | 30 (27.3) | 0.757 (0.398-1.441) | 0.397 | 22 (20.0) | 0.566 (0.294-1.090) | 0.089 | 17 (15.5) | 0.521 (0.255-1.067) | 0.075 |
4 | 24 (21.8) | 0.711 (0.367-1.376) | 0.311 | 16 (14.5) | 0.385 (0.187-0.795) | 0.010 | 12 (10.9) | 0.358 (0.160-0.799) | 0.012 |
*ORs were calculated by unconditional logistic regression analysis and adjusted for pathologic stage and grade; †Preoperative BMI was classified by quartiles of the range: quartile 1, <21.7 kg/m2; quartile 2, 21.7-23.7 kg/m2; quartile 3, 23.8-25.7 kg/m2; quartile 4, ≥25.8 kg/m2. BMI, body mass index; CSM, cancer specific mortality; OM, overall mortality; CI, confidence interval; OR, odds ratio.